Unimark Remedies Limited - Company Profile

Q: Who are the current directors of Unimark Remedies Limited?

The current directors of Unimark Remedies Limited are Sonalika Sushant Shrivastav, Jitesh Khokhani Rameshchandra, Ketan Bhupendrabhai Parikh, Kamlesh Rameshchandra Khokhani, Kamlesh Rameshchandra Khokhani.

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1993.

1993 Mumbai, Maharashtra, India Active

Last Updated: December 23, 2025

Access Report

About Unimark Remedies Limited

Unimark Remedies Limited, a active public limited company, was established on 01 December 1993 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U23200MH1993PLC075373. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹57.01 Cr and a paid-up capital of ₹10.00 Cr.

Formerly known as Unimark Remedies Private Limited. It upholds a compliant status. Employing 4 professional, Its leadership includes Sonalika Sushant Shrivastav (Additional Director), Jitesh Khokhani Rameshchandra (Director), Ketan Bhupendrabhai Parikh (Additional Director). Past directors included Shekhar Ramchandra Shanbhag, Om Dutt Tyagi, Sanjeev Anant Gupte. It holds ₹1,105.65 Cr open charges and ₹344.73 Cr settled loans. Its latest AGM occurred on 29 December 2018, with the balance sheet filed on 31 March 2018. It is based at Plot -83C, Ground Floor, Motor Cycle Building, Laxminarsingh, Papan Marg, Off. Dr. E Moses Road, Gandhi Nagar, Worli, Mumbai, Maharashtra, 400018.

Company Details

CIN/LLPIN
U23200MH1993PLC075373
Registration Number
075373
Incorporation Date
01 December 1993
Authorized Capital
₹57.01 Cr
Paid-Up Capital
₹10.00 Cr
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 57.01 Cr as on 23-12-2025
Paid Up Capital ₹ 10.00 Cr as on 23-12-2025
Company Age 32 Year, 2 Months
Last Filing with ROC 31 Mar 2018
Open Charges ₹ 1,105.65 Cr as on 23-12-2025
Satisfied Charges ₹ 344.73 Cr as on 23-12-2025
Revenue Growth **** -30.01% (FY 2019)
Profit Growth **** 38.94% (FY 2019)
Ebitda **** 60.24% (FY 2019)
Net Worth -30.94% (FY 2019)
Total Assets -8.66% (FY 2019)

Comprehensive Company Insights

Explore comprehensive insights into Unimark Remedies Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Unimark Remedies Limited?

Current Directors

Name	Designation	Appointment Date	Status
Sonalika Sushant Shrivastav	Additional Director	06 Sep 2024	Current
Jitesh Khokhani Rameshchandra	Director	26 May 2023	Current
Ketan Bhupendrabhai Parikh	Additional Director	27 May 2023	Current
Kamlesh Rameshchandra Khokhani	Cfo	06 Sep 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	29 Sep 2011	Past
Pramod Abcsdd	Whole-Time Director	17 Oct 2016	Past
Pramod Abcsdd	Director	13 Feb 2014	Past
Pramod Abcsdd	Director	31 May 2013	Past
Pramod Abcsdd	Director	31 Mar 2008	Past
Pramod Abcsdd	Cfo(Kmp)	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Unimark Remedies.

Unimark Remedies Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 30.01% decrease. The company also saw a substantial improvement in profitability, with a 38.94% increase in profit. The company's net worth observed a substantial decline by a decrease of 30.94%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-30.01%

*******

Revenue from Operations

*******

-30.22%

*******

Total Assets

*******

-8.66%

*******

Profit or Loss

*******

38.94%

*******

Net Worth

*******

-30.94%

*******

EBITDA

*******

60.24%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Unimark Remedies?

In 2018, Unimark Remedies had a promoter holding of 18.08% and a public holding of 81.92%. The company had 2 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹11,056,450,266.00

Satisfied Charges

₹3,447,303,686.00

Charges Breakdown by Lending Institutions

Idbi Trusteeship Services Limited : 913.75 Cr
Others : 142.83 Cr
Citi Bank N.A. : 41.00 Cr
Canara Bank : 6.95 Cr
Sidbi : 1.00 Cr
Others : 0.11 Cr

Latest Charge Details

Date	Lender	Amount	Status
02 Sep 2025	Others	₹35.00 Cr	Open
30 Jul 2024	Others	₹50.00 Cr	Open
03 Jun 2014	Idbi Trusteeship Services Limited	₹913.75 Cr	Open
06 Mar 2013	Others	₹1.80 Cr	Open
06 Mar 2013	Others	₹4.90 M	Open

Explore comprehensive loan charge details -

How Many Employees Work at Unimark Remedies?

Unimark Remedies has a workforce of 4 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Unimark Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unimark Remedies's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Unimark Remedies

Recent Activity within the Organization

Charges

Progress on A charge with Others amounted to Rs. 35.00 Cr with Charge ID 101158384 was registered on 02 Sep 2025. was documented.
02 Sep 2025
Director Appointment

Progress on Kamlesh Rameshchandra Khokhani was appointed as a Cfo was appointed as a Cfo on 16 Aug 2025 & has been associated with this company since 6 months 7 days . was documented.
16 Aug 2025
Charges

A charge registered on 22 Sep 2009 via Charge ID 10176412 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 06 Aug 2025. was recorded as a recent event.
06 Aug 2025
Charges

The activity A charge registered on 27 May 2008 via Charge ID 10141701 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 06 Aug 2025. was completed.
06 Aug 2025
Charges

A charge registered on 02 Apr 2007 via Charge ID 10050722 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 06 Aug 2025. was recorded as a recent event.
06 Aug 2025
Charges

Progress on A charge registered on 02 Apr 2007 via Charge ID 10049603 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 06 Aug 2025. was documented.
06 Aug 2025

Explore recent activity and updates - View Recent Activity